
CCLG Research Talks: How biobanking supports childhood cancer research
Hear from Dr John Moppett about what the VIVO biobank is and how it supports expert childhood cancer research.
Hear from Dr John Moppett about what the VIVO biobank is and how it supports expert childhood cancer research.
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to Cambridge to find out...
On 23 April 2024, the TYAC Professional Education Group is running a session aimed at helping staff better understand the experiences of young people with cancer as part of Children's Cancer and Leukaemia Group's (CCLG) Annual Conference.
Childhood cancer researchers looking at the composition of a childhood brain tumour called ependymoma have made a key breakthrough in the way this disease is understood. For years, treatments for ependymoma have seen limited progress, with no major breakthroughs on the horizon for these young...
Children's Cancer and Leukaemia Group (CCLG) has partnered with Young Lives vs Cancer to fund a new research project that will assess the benefits and challenges of administering chemotherapy at home to children with cancer. The goal of this jointly funded project is to understand more...
New research into a rare type of leukaemia has been funded, thanks to several Children's Cancer and Leukaemia Group (CCLG) Special Named Funds.
A family fundraising for children’s cancer research in memory of their 16-year-old son fulfilled their promise to him that they would raise £100,000 before the second anniversary of his death.
Connie was diagnosed with high-risk medulloblastoma, a childhood brain tumour, in October 2022. Her mum, Tina, shares her story.
Stanley was diagnosed with group A posterior fossa ependymoma, a type of childhood brain tumour, when he was six years old. His mum, Kirsty, shares his story.